I don't understand the fda here. They refused to approve the drug over a period of years. Nothing was really new in the data. Why would they have changed their thinking? I think the sole advantage of the drug is less weight gain. This decision makes the whole review process seem somewhat arbitrary. It's all in the timing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.